LUCERNE Study (Protocol number: GR40844)
A two year multicentre, randomized, double-masked, active comparator controlled study to evaluate the efficacy and safety of Faricimab in participants with Neovascular Age-Related Macular Degeneration.
ClinicalTrials.gov Identifier: NCT03823300
Principal Investigator: Dr Balaratnasingam, Chandra
For further information about this study, you may visit Clinical Trial Registry:
https://clinicaltrials.gov/ct2/show/NCT03823300?term=LUCERNE&draw=2&rank=4
Or contact the Lions Eye Institute Clinical Trials Office telephone (08) 9381 0750 or email clinicalresearch@lei.org.au
